US EditionPublished • loading... • Updated
Thousands Lose Care as a Result of NIH Grant Terminations
NIH funding cuts halted 383 trials impacting over 74,000 participants, with disruptions especially in HIV, COVID-19, mental health, and cancer research, some grants later reinstated by courts.
- A JAMA Internal Medicine analysis shows 383 NIH-funded clinical trials lost funding between late February and August this year, affecting more than 74,000 participants nationwide.
- The policy cut terminated hundreds of NIH grants, citing concerns about 'wasteful' or 'discriminatory' research, after legal actions involving the Supreme Court and federal judges.
- Studies focusing on infectious disease prevention and behavioral health, along with more than 100 cancer trials, were hardest hit, and an HIV prevention PrEP trial serving Black and Hispanic men saw a Jackson, Mississippi clinic shut down.
- A federal judge later ordered hundreds of grants reinstated, including the PrEP trial led by Amy Nunn and Dr. Philip Chan, after enrollment and operations stopped at many clinical trial sites and participants lost access to care.
- Researchers fear brief pauses risk ruining trials needing consistent dosing, and clinical research infrastructure losses are hard to rebuild, jeopardizing future public-health research.
Insights by Ground AI
20 Articles
20 Articles
NIH Grant Cuts Leave Hundreds of Clinical Trials, 74,000 Patients in Limbo, Study Finds
Hundreds of federally funded clinical trials, enrolling more than 74,000 patients, were disrupted this year after the National Institutes of Health abruptly terminated billions of dollars in research grants, a study found.
·United States
Read Full ArticleCoverage Details
Total News Sources20
Leaning Left5Leaning Right3Center7Last UpdatedBias Distribution47% Center
Bias Distribution
- 47% of the sources are Center
47% Center
L 33%
C 47%
R 20%
Factuality
To view factuality data please Upgrade to Premium
